The wnt pathway in mood disorders

Gabriele Sani, Flavia Napoletano, Alberto Maria Forte, Giorgio D. Kotzalidis, Isabella Panaccione, Giulio Maria Porfiri, Alessio Simonetti, Matteo Caloro, Nicoletta Girardi, Carla Ludovica Telesforo, Giulia Serra, Silvia Romano, Giovanni Manfredi, Valeria Savoja, Stefano Maria Tamorri, Alexia E. Koukopoulos, Daniele Serata, Chiara Rapinesi, Antonio Del Casale, Ferdinando NicolettiPaolo Girardi

Research output: Contribution to journalArticle

Abstract

Objectives: To review the evidence of the involvement of the Wnt signalling pathway in mood disorders and in the action of drugs used to treat these disorders. Methods: We performed a careful PubMed search using as keywords all possible terms relevant to the Wnt pathway and crossing them with each of four areas, i.e., developmental effects, behavioural effects, mood disorders, and drugs used in their treatment. Papers were selected on the basis of their content and their data used for discussion. Results: Neurodevelopmental and behavioural data point to the possibility of involvement of the Wnt pathway in the pathophysiology of mood disorders. Clinical and post-mortem data are not sufficient to corroborate a definite role for Wnt alterations in any mood disorder. Combining genetic and pharmacological data, we may state that glycogen synthase kinase is the key molecule in bipolar disorder, as it is connected with many other signalling pathways that were shown to be involved in mood disorders, while Wnt molecules in the hippocampus appear to be mainly involved in depressive disorders. Conclusions: Altered Wnt signalling may play a role in the pathophysiology of mood disorders, although not a central one. It is premature to draw conclusions regarding the possible usefulness of Wnt manipulations in the treatment of mood disorders.

Original languageEnglish
Pages (from-to)239-253
Number of pages15
JournalCurrent Neuropharmacology
Volume10
Issue number3
DOIs
Publication statusPublished - 2012

Fingerprint

Wnt Signaling Pathway
Mood Disorders
Glycogen Synthase Kinases
Depressive Disorder
Bipolar Disorder
PubMed
Pharmaceutical Preparations
Hippocampus
Pharmacology

Keywords

  • Antidepressant Drugs
  • Antipsychotic Drugs
  • Bipolar Disorder
  • Major Depression
  • Mood Disorders
  • Mood Stabilising Agents
  • Wingless (Wnt) signalling

ASJC Scopus subject areas

  • Clinical Neurology
  • Pharmacology (medical)
  • Pharmacology
  • Neurology
  • Psychiatry and Mental health

Cite this

Sani, G., Napoletano, F., Forte, A. M., Kotzalidis, G. D., Panaccione, I., Porfiri, G. M., ... Girardi, P. (2012). The wnt pathway in mood disorders. Current Neuropharmacology, 10(3), 239-253. https://doi.org/10.2174/157015912803217279

The wnt pathway in mood disorders. / Sani, Gabriele; Napoletano, Flavia; Forte, Alberto Maria; Kotzalidis, Giorgio D.; Panaccione, Isabella; Porfiri, Giulio Maria; Simonetti, Alessio; Caloro, Matteo; Girardi, Nicoletta; Telesforo, Carla Ludovica; Serra, Giulia; Romano, Silvia; Manfredi, Giovanni; Savoja, Valeria; Tamorri, Stefano Maria; Koukopoulos, Alexia E.; Serata, Daniele; Rapinesi, Chiara; Casale, Antonio Del; Nicoletti, Ferdinando; Girardi, Paolo.

In: Current Neuropharmacology, Vol. 10, No. 3, 2012, p. 239-253.

Research output: Contribution to journalArticle

Sani, G, Napoletano, F, Forte, AM, Kotzalidis, GD, Panaccione, I, Porfiri, GM, Simonetti, A, Caloro, M, Girardi, N, Telesforo, CL, Serra, G, Romano, S, Manfredi, G, Savoja, V, Tamorri, SM, Koukopoulos, AE, Serata, D, Rapinesi, C, Casale, AD, Nicoletti, F & Girardi, P 2012, 'The wnt pathway in mood disorders', Current Neuropharmacology, vol. 10, no. 3, pp. 239-253. https://doi.org/10.2174/157015912803217279
Sani G, Napoletano F, Forte AM, Kotzalidis GD, Panaccione I, Porfiri GM et al. The wnt pathway in mood disorders. Current Neuropharmacology. 2012;10(3):239-253. https://doi.org/10.2174/157015912803217279
Sani, Gabriele ; Napoletano, Flavia ; Forte, Alberto Maria ; Kotzalidis, Giorgio D. ; Panaccione, Isabella ; Porfiri, Giulio Maria ; Simonetti, Alessio ; Caloro, Matteo ; Girardi, Nicoletta ; Telesforo, Carla Ludovica ; Serra, Giulia ; Romano, Silvia ; Manfredi, Giovanni ; Savoja, Valeria ; Tamorri, Stefano Maria ; Koukopoulos, Alexia E. ; Serata, Daniele ; Rapinesi, Chiara ; Casale, Antonio Del ; Nicoletti, Ferdinando ; Girardi, Paolo. / The wnt pathway in mood disorders. In: Current Neuropharmacology. 2012 ; Vol. 10, No. 3. pp. 239-253.
@article{4130f17cbfe545da8ae2f111ad7d856f,
title = "The wnt pathway in mood disorders",
abstract = "Objectives: To review the evidence of the involvement of the Wnt signalling pathway in mood disorders and in the action of drugs used to treat these disorders. Methods: We performed a careful PubMed search using as keywords all possible terms relevant to the Wnt pathway and crossing them with each of four areas, i.e., developmental effects, behavioural effects, mood disorders, and drugs used in their treatment. Papers were selected on the basis of their content and their data used for discussion. Results: Neurodevelopmental and behavioural data point to the possibility of involvement of the Wnt pathway in the pathophysiology of mood disorders. Clinical and post-mortem data are not sufficient to corroborate a definite role for Wnt alterations in any mood disorder. Combining genetic and pharmacological data, we may state that glycogen synthase kinase is the key molecule in bipolar disorder, as it is connected with many other signalling pathways that were shown to be involved in mood disorders, while Wnt molecules in the hippocampus appear to be mainly involved in depressive disorders. Conclusions: Altered Wnt signalling may play a role in the pathophysiology of mood disorders, although not a central one. It is premature to draw conclusions regarding the possible usefulness of Wnt manipulations in the treatment of mood disorders.",
keywords = "Antidepressant Drugs, Antipsychotic Drugs, Bipolar Disorder, Major Depression, Mood Disorders, Mood Stabilising Agents, Wingless (Wnt) signalling",
author = "Gabriele Sani and Flavia Napoletano and Forte, {Alberto Maria} and Kotzalidis, {Giorgio D.} and Isabella Panaccione and Porfiri, {Giulio Maria} and Alessio Simonetti and Matteo Caloro and Nicoletta Girardi and Telesforo, {Carla Ludovica} and Giulia Serra and Silvia Romano and Giovanni Manfredi and Valeria Savoja and Tamorri, {Stefano Maria} and Koukopoulos, {Alexia E.} and Daniele Serata and Chiara Rapinesi and Casale, {Antonio Del} and Ferdinando Nicoletti and Paolo Girardi",
year = "2012",
doi = "10.2174/157015912803217279",
language = "English",
volume = "10",
pages = "239--253",
journal = "Current Neuropharmacology",
issn = "1570-159X",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - The wnt pathway in mood disorders

AU - Sani, Gabriele

AU - Napoletano, Flavia

AU - Forte, Alberto Maria

AU - Kotzalidis, Giorgio D.

AU - Panaccione, Isabella

AU - Porfiri, Giulio Maria

AU - Simonetti, Alessio

AU - Caloro, Matteo

AU - Girardi, Nicoletta

AU - Telesforo, Carla Ludovica

AU - Serra, Giulia

AU - Romano, Silvia

AU - Manfredi, Giovanni

AU - Savoja, Valeria

AU - Tamorri, Stefano Maria

AU - Koukopoulos, Alexia E.

AU - Serata, Daniele

AU - Rapinesi, Chiara

AU - Casale, Antonio Del

AU - Nicoletti, Ferdinando

AU - Girardi, Paolo

PY - 2012

Y1 - 2012

N2 - Objectives: To review the evidence of the involvement of the Wnt signalling pathway in mood disorders and in the action of drugs used to treat these disorders. Methods: We performed a careful PubMed search using as keywords all possible terms relevant to the Wnt pathway and crossing them with each of four areas, i.e., developmental effects, behavioural effects, mood disorders, and drugs used in their treatment. Papers were selected on the basis of their content and their data used for discussion. Results: Neurodevelopmental and behavioural data point to the possibility of involvement of the Wnt pathway in the pathophysiology of mood disorders. Clinical and post-mortem data are not sufficient to corroborate a definite role for Wnt alterations in any mood disorder. Combining genetic and pharmacological data, we may state that glycogen synthase kinase is the key molecule in bipolar disorder, as it is connected with many other signalling pathways that were shown to be involved in mood disorders, while Wnt molecules in the hippocampus appear to be mainly involved in depressive disorders. Conclusions: Altered Wnt signalling may play a role in the pathophysiology of mood disorders, although not a central one. It is premature to draw conclusions regarding the possible usefulness of Wnt manipulations in the treatment of mood disorders.

AB - Objectives: To review the evidence of the involvement of the Wnt signalling pathway in mood disorders and in the action of drugs used to treat these disorders. Methods: We performed a careful PubMed search using as keywords all possible terms relevant to the Wnt pathway and crossing them with each of four areas, i.e., developmental effects, behavioural effects, mood disorders, and drugs used in their treatment. Papers were selected on the basis of their content and their data used for discussion. Results: Neurodevelopmental and behavioural data point to the possibility of involvement of the Wnt pathway in the pathophysiology of mood disorders. Clinical and post-mortem data are not sufficient to corroborate a definite role for Wnt alterations in any mood disorder. Combining genetic and pharmacological data, we may state that glycogen synthase kinase is the key molecule in bipolar disorder, as it is connected with many other signalling pathways that were shown to be involved in mood disorders, while Wnt molecules in the hippocampus appear to be mainly involved in depressive disorders. Conclusions: Altered Wnt signalling may play a role in the pathophysiology of mood disorders, although not a central one. It is premature to draw conclusions regarding the possible usefulness of Wnt manipulations in the treatment of mood disorders.

KW - Antidepressant Drugs

KW - Antipsychotic Drugs

KW - Bipolar Disorder

KW - Major Depression

KW - Mood Disorders

KW - Mood Stabilising Agents

KW - Wingless (Wnt) signalling

UR - http://www.scopus.com/inward/record.url?scp=84867564968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867564968&partnerID=8YFLogxK

U2 - 10.2174/157015912803217279

DO - 10.2174/157015912803217279

M3 - Article

C2 - 23449817

AN - SCOPUS:84867564968

VL - 10

SP - 239

EP - 253

JO - Current Neuropharmacology

JF - Current Neuropharmacology

SN - 1570-159X

IS - 3

ER -